Adamas Pharma's Gocovri Will Achieve 'Blockbuster' Status, Says Kerrisdale
November 01, 2017 at 11:29 AM EDT
Adamas Pharmaceuticals Inc (NASDAQ: ADMS), a small-cap pharmaceutical company that develops therapies to treat chronic neurologic ...